Prostate Cancer : Detection of Lymph Node Metastases Outside the Routine Surgical Area with Ferumoxtran-10 – enhanced MR Imaging 1

Roel A. M. Heesakkers, MD Gerrit J. Jager, MD, PhD Anke M. Hövels, MSc Bartjan de Hoop, MD Harrie C. M. van den Bosch, MD Frank Raat, MD J. Alfred Witjes, MD, PhD Peter F. A. Mulders, MD, PhD Christina Hulsbergen van der Kaa, MD, PhD Jelle O. Barentsz, MD, PhD Purpose: To prospectively evaluate the feasibility of magnetic resonance (MR) imaging with ferumoxtran-10 in patients with prostate cancer to depict lymph node metastases outside the routine pelvic lymph node dissection (PLND) area.

[1]  J. Montie.  Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. , 2005, The Journal of urology.

[2]  F. Burkhard,et al.  The role of lymphadenectomy in prostate cancer , 2005, Nature Clinical Practice Urology.

[3]  W. Sega,et al.  Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. , 2005, The Journal of urology.

[4]  B. Esterni,et al.  Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  Jie Cai,et al.  Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. , 2004, The Journal of urology.

[6]  B. Trock,et al.  Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. , 2004, The Journal of urology.

[7]  J. Kaouk,et al.  Laparoscopic extended pelvic lymphadenectomy for bladder cancer: technique and initial outcomes. , 2004, The Journal of urology.

[8]  F. Burkhard,et al.  Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? , 2003, The Journal of urology.

[9]  Ralph Weissleder,et al.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.

[10]  G. Muir,et al.  Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in “high‐risk” prostate cancer compared to MRI or CT , 2003, Scandinavian journal of urology and nephrology.

[11]  Sam S. Chang,et al.  Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. , 2003, The Journal of urology.

[12]  A. Heidenreich,et al.  Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. , 2002, The Journal of urology.

[13]  P. Unger,et al.  Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques. , 1997, The Journal of urology.

[14]  J. Witjes,et al.  Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. , 1996, AJR. American journal of roentgenology.

[15]  T. Shankey,et al.  Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy. , 1996, Urology.

[16]  W. Schuessler,et al.  Laparoscopic standard pelvic node dissection for carcinoma of the prostate: is it accurate? , 1993, The Journal of urology.

[17]  D. Johnson,et al.  Pelvic lymphadenectomy for staging clinically localized prostate cancer. Indications, complications, and results in 217 cases. , 1990, Urology.

[18]  R B Jeffrey,et al.  Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging. , 1987, Radiology.

[19]  C. Brendler,et al.  Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit. , 1980, The Journal of urology.

[20]  N. V. Raghavaiah,et al.  Prostatic lymphography. , 1979, Journal of Urology.